Literature DB >> 9423167

Carboxylesterase-mediated transesterification of meperidine (Demerol) and methylphenidate (Ritalin) in the presence of [2H6]ethanol: preliminary in vitro findings using a rat liver preparation.

J A Bourland, D K Martin, M Mayersohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9423167     DOI： 10.1021/js970072x

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  10 in total

1.  Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery.

Authors:  Guinevere H Bell; William C Griffin; Kennerly S Patrick
Journal:  Pharmacol Biochem Behav       Date:  2011-09-08       Impact factor: 3.533

Review 2.  Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.

Authors:  James H Ho; George P Bailey; John R H Archer; Paul I Dargan; David M Wood
Journal:  Eur J Clin Pharmacol       Date:  2015-07-22       Impact factor: 2.953

3.  Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.

Authors:  Guinevere H Bell; Andrew J Novak; William C Griffin; Kennerly S Patrick
Journal:  J Pharm Sci       Date:  2011-01-14       Impact factor: 3.534

Review 4.  The role of human carboxylesterases in drug metabolism: have we overlooked their importance?

Authors:  S Casey Laizure; Vanessa Herring; Zheyi Hu; Kevin Witbrodt; Robert B Parker
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

5.  Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.

Authors:  S Casey Laizure; Robert B Parker; Vanessa L Herring; Zhe-Yi Hu
Journal:  Drug Metab Dispos       Date:  2013-11-08       Impact factor: 3.922

6.  Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans.

Authors:  Kennerly S Patrick; Arthur B Straughn; Owen T Reeves; Hilary Bernstein; Guinevere H Bell; Erica R Anderson; Robert J Malcolm
Journal:  Drug Metab Dispos       Date:  2012-10-25       Impact factor: 3.922

7.  Physiologically based pharmacokinetic modeling of impaired carboxylesterase-1 activity: effects on oseltamivir disposition.

Authors:  Zhe-Yi Hu; Andrea N Edginton; S Casey Laizure; Robert B Parker
Journal:  Clin Pharmacokinet       Date:  2014-09       Impact factor: 6.447

8.  In vitro and in vivo trans-esterification of 1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]-3(S)-benzyl-piperidine-3-carboxylic acid ethyl ester and the effects of ethanol on its pharmacokinetics in rats.

Authors:  Zhesheng Chen; Arun K Agrawal; Ronald B Franklin; Kwan H Leung; Shuet-Hing Lee Chiu
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 9.  Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.

Authors:  Kennerly S Patrick; Timothy R Corbin; Cristina E Murphy
Journal:  J Pharm Sci       Date:  2014-10-09       Impact factor: 3.534

10.  In Vitro Neurochemical Assessment of Methylphenidate and Its "Legal High" Analogs 3,4-CTMP and Ethylphenidate in Rat Nucleus Accumbens and Bed Nucleus of the Stria Terminalis.

Authors:  Colin Davidson; Christopher A R Raby; Vincenzo Barrese; John Ramsey
Journal:  Front Psychiatry       Date:  2018-05-28       Impact factor: 4.157
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.